Home LiteratureArticle Details
PMID: 20211010 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Gene expression signatures in childhood acute leukemias are largely unique and distinct from those of normal tissues and other malignancies.

BMC medical genomics ·Vol. 3 ·2010-03-08 ·页码 6

Andersson A, Edén P, Olofsson T, Fioretos T

Abstract

Childhood leukemia is characterized by the presence of balanced chromosomal translocations or by other structural or numerical chromosomal changes. It is well know that leukemias with specific molecular abnormalities display profoundly different global gene expression profiles. However, it is largely unknown whether such subtype-specific leukemic signatures are unique or if they are active also in non-hematopoietic normal tissues or in other human cancer types. Using gene set enrichment analysis, we systematically explored whether the transcriptional programs in childhood acute lymphoblastic leukemia (ALL) and myeloid leukemia (AML) were significantly similar to those in different flow-sorted subpopulations of normal hematopoietic cells (n = 8), normal non-hematopoietic tissues (n = 22) or human cancer tissues (n = 13). This study revealed that e.g., the t(12;21) [ETV6-RUNX1] subtype of ALL and the t(15;17) [PML-RARA] subtype of AML had transcriptional programs similar to those in normal Pro-B cells and promyelocytes, respectively. Moreover, the 11q23/MLL subtype of ALL showed similarities with non-hematopoietic tissues. Strikingly however, most of the transcriptional programs in the other leukemic subtypes lacked significant similarity to approximately 100 gene sets derived from normal and malignant tissues. This study demonstrates, for the first time, that the expression profiles of childhood leukemia are largely unique, with limited similarities to transcriptional programs active in normal hematopoietic cells, non-hematopoietic normal tissues or the most common forms of human cancer. In addition to providing important pathogenetic insights, these findings should facilitate the identification of candidate genes or transcriptional programs that can be used as unique targets in leukemia.

MeSH 主题词
Gene Expression Regulation, Leukemic Granulocyte Precursor Cells/metabolism Humans Leukemia, Myeloid, Acute/genetics Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics Precursor Cells, B-Lymphoid/metabolism Proto-Oncogene Proteins c-ets/genetics,metabolism Repressor Proteins/genetics,metabolism Translocation, Genetic Up-Regulation
化学物质
ETS translocation variant 6 protein Proto-Oncogene Proteins c-ets Repressor Proteins
作者与单位
共 4 位作者,点击展开单位 / ORCID
Andersson Anna
Section of Clinical Genetics, Department of Laboratory Medicine, Lund University Hospital, Lund, Sweden. [email protected]
Edén Patrik
Olofsson Tor
Fioretos Thoas
Article Info
Journal
BMC medical genomics
Abbr.
BMC Med Genomics
ISSN
1755-8794
Corresponding email
Published
2010-03-08
电子出版
2010-00-08
页码
6
Language
English
Country/Region
England
NLM ID
101319628
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]